Nicholas A. Boyle
Oprichter bij Abintus Bio, Inc.
Profiel
Nicholas A.
Boyle is the founder.
He founded Abintus Bio, Inc. in 2020 and currently holds the titles of President, Chief Executive Officer & Director.
Dr. Boyle's former job positions include Director-Corporate Development at Spectrum Pharmaceuticals, Inc. from 2007 to 2009, Vice President-Business Development & Marketing at Tocagen, Inc., and Principal at GlaxoSmithKline LLC and Biota, Inc. In terms of education, Dr. Boyle obtained an undergraduate and doctorate degree from The University of Sheffield.
He also holds an MBA from the University of California.
Actieve functies van Nicholas A. Boyle
| Bedrijven | Functie | Begin |
|---|---|---|
Abintus Bio, Inc.
 Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Oprichter | 15-04-2020 |
Eerdere bekende functies van Nicholas A. Boyle
| Bedrijven | Functie | Einde |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-12-2009 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| Biota, Inc. | Corporate Officer/Principal | - |
| FORTE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Opleiding van Nicholas A. Boyle
| The University of Sheffield | Doctorate Degree |
| University of California | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Tocagen, Inc.
 Tocagen, Inc. BiotechnologyHealth Technology Tocagen, Inc. is a clinical-stage, cancer-selective gene therapy company, which engages in the development of product candidates designed to activate a patient's immune system against their own cancer. It is in the business of discovery, development, and commercialization of products for the treatment of cancer. The company was founded by Thomas E. Darcy, Harry E. Gruber, Douglas J. Jolly, and Dennis N. Berman in August 2007 and is headquartered San Diego, CA. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
| Biota, Inc. | |
Abintus Bio, Inc.
Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Commercial Services |
